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Mangrove endophytic fungi continue to attract attention as 
prolific sources of structurally unprecedented bioactive natural 
products.1 It has been hypothesized that these endophytes have 
developed unique metabolic mechanisms as a response to 
various stress factors in Mangrove habitats, such as high salinity 
and intertidal zone alterations.2,3 Indeed, our previous work on 
the Mangrove endophytic fungus Phomopsis longicolla, 
afforded the tetrahydroxanthone derivative phomoxanthone A, 
which showed selective pro-apoptotic activity toward several 
cancer cell lines, including cisplatin resistant ones, parallel to 
potent immunostimulatory capacity on murine T cells, NK cells, 
and macrophages.4,5 
During our ongoing search for structurally unique secondary 
metabolites from Mangrove endophytic fungi,6,7,8 the fungus 
Annulohypoxylon sp. which was obtained from the Mangrove 
plant Rhizophora racemosa, yielded several new daldinone 
derivatives.9 As a continuation of this work, a novel macrolide, 
hypoxylide (1), possessing an unprecedented 
trihydroxynaphthalene-dione moiety fused to a decalactone ring 
is now reported (Figure 1). 
 
Figure 1. Structure of compound 1 
 
Hypoxylide (1) was obtained as a light yellowish, amorphous 
solid. Its molecular formula was established as C20H22O8 on the 
basis of the prominent ion peak observed at m/z 391.1389 [M + 
H]+ in the HRESIMS spectrum, accounting for 13 degrees of 
unsaturation. The 1H NMR spectrum of 1, measured in MeOH-
d4, revealed representative signals of five sets of methylene 
groups resonating at δH 2.68/2.51 (H2-8'), 1.95/1.31 (H2-2'), 
1.86/1.10 (H2-1'), 1.81/1.55 (H2-3'), and 1.64/1.21 (H2-7), one 
aliphatic proton at δH 2.61 (H-6), one methyl group at δH 1.24 (4'-
CH3), one oxymethine proton at δH 4.70 (H-4'), and two meta-
coupled aromatic protons at δH 6.27 (J = 2.4 Hz; H-2) and 6.61 
(J = 2.4 Hz; H-4). The 13C NMR spectrum of 1 showed 20 
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resonances attributable to two keto groups at δc 203.6 (C-11) and 
195.5 (C-10), one ester group at δc 169.7 (C-8''), one benzene 
ring (δc 165.5, 164.5, 144.9, 112.0, 106.7, and 101.7; C-10a – C-
4a), and 11 aliphatic sp3 carbons (Supporting information Table 
S1). Detailed analysis of the COSY and HSQC NMR spectra 
revealed a long continuous spin system starting from the 
methylene group CH2-7 and sequentially extending until the 
methyl group 4'-CH3 (Figure 2). This spin system was confirmed 
by HMBC correlations from H2-7 to C-6 and C-1', from H2-1' to 
C-6, C-2', and C-3', from H2-3' to C-2', C-4', and 4'-CH3, as well 
as from 4'-CH3 to C-3' and C-4'. In addition, the HMBC 
correlations from the methylene group H2-8' to C-8, C-7, and C-
8'', and from H-4' to C-8'' corroborated the existence of a 10-
membered macrocyclic ring in 1 (Figure 2). The remaining 
HMBC correlations from H-2 to C-10a, C-1, C-3 and C-4, as 
well as from H-4 to C-10a, C-2, and C-3 further established the 
presence of a benzene ring (C-10a – C-4a). 
Further NMR analysis of 1, using DMSO-d6 as solvent, 
afforded key HMBC correlations from 3-OH (δH 11.01) to C-2 
and C-4, as well as from a chelated hydroxy group (δH 12.48, 1-
OH) to C-10a, C-1, and C-2, thus assigning the location of two 
OH groups in the benzene ring at C-3 and C-1, respectively. 
Additional HMBC correlations from H-9 to C-11 and C-5, as 
well as from 5-OH to C-4a, C-5, and C-11 suggested the 
remaining keto group being located at C-11, thus indicating a 
1,3-naphthalene-dione moiety in the structure of 1. Finally, the 
connection of this substructure with the lactone ring was 
established based on the HMBC correlations from 5-OH to C-6, 
from H-9 to C-8, C-7, and C-8', from 8-OH to C-7, C-8, C-9, and 
C-8', as well as from H2-7 to C-5 and C-9 (Figure 2). 
 
Figure 2. Selected HMBC and COSY correlations of 1
 
Table 1. 1H (600 MHz) and 13C (150 MHz) NMR data of 1 (MeOH-d4 and DMSO-d6, δ in ppm) 
 
 1 ( in MeOH-d4 )  1 ( in DMSO-d6 ) 
Position δC  δH, mult. (J in Hz)  δC  δH, mult. (J in Hz) 
1 164.5   163.7  
2 101.7 6.27, d (2.4)  101.7 6.25, d (2.3) 
3 165.5   165.2  
4 106.7 6.61, d (2.4)  106.9 6.54, d (2.3) 
4a 144.9   145.4  
5 80.3   80.2  
6 40.1 2.61, ddt (12.8, 12.0, 3.0)  39.5 2.47 (overlapping)  
7 34.4 a: 1.64, dd (15.0, 12.0) 
b: 1.21, dd (15.0, 1.1) 
 34.6 a: 1.44, br d (14.2) 
b: 1.06, br t (14.2) 
8 74.7   75.2  
9 74.6 3.31 (overlapping)  74.8 3.46, d (1.0) 
10 195.5   195.6  
10a 112.0   111.7  
11 203.6   203.8  
1' 25.3 a: 1.10, ddt (13.4, 12.8, 3.5) 
b: 1.86, tdd (13.4, 4.6, 3.0) 
 25.1 a: 0.93, br t (12.8) 
b: 1.71, m 
2' 23.7 a: 1.95, dddd (14.8, 13.4, 10.5, 3.5) 
b: 1.31, dddd (14.8, 9.6, 4.6, 3.5) 
 23.5 a: 1.83, m  
b: 1.18, m 
3' 34.5 a: 1.81, dd (15.6, 10.5) 
b: 1.55, dt (15.6, 9.6) 
 34.1 a: 1.73, m  
b: 1.45, m 
4' 75.7 4.70, dq (9.6, 6.2)  74.9 4.58, dd (9.9, 6.3) 
4'-CH3 20.7 1.24, d (6.2)  21.7 1.18, d (6.3) 
8' 44.8 a: 2.68, d (12.8) 
b: 2.51, dd (12.8, 3.0) 
 44.7 a: 2.54, dd (12.8, 3.2) 
b: 2.45, dd (12.8, 2.6) 
8'' 169.7   168.9  
1-OH     12.48, s 
3-OH     11.01, s 
5-OH     6.11, s 
8-OH     5.82, br s 
 
The relative configuration of 1 was deduced by analysis of the 
coupling constants and the ROESY spectrum. Accordingly, key 
correlations of H-9 with H-8'a and H-8'b, as well as of H-1'b with 
both H-6 and 5-OH suggested the co-facial orientation of the 
respective protons. Consequently, 8-OH was oriented on the 
opposite side based on its correlations with both H-7a and H-7b, 
suggesting a chair conformation for the cyclohexanone ring. The 
axial orientation of H-6 was corroborated by its ROESY 
correlation with H-3'b, as well as by the large vicinal coupling 
constants with H-7a and H-1'a (3JH-6, H-7a = 12.0 Hz and 3JH-6, H-1'a = 
12.8 Hz, respectively). Finally, the ROESY cross-peaks of 4'-CH3 
with H-3'a and of H-4' with H-7b indicated the equatorial 
orientation of 4'-CH3 in the lactone ring, which is in agreement 
with the large coupling constant (9.6 Hz) between H-4' and H-3'b 
(Table S1). Hence, the relative configuration 
(5S*,6S*,8S*,9S*,4'S*) was deduced for 1 as shown in Figure 3. 
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Figure 3. ROESY correlations of the arbitrarily chosen 
enantiomer (5S, 6S, 8S, 9S, 4'S)-1 
For the determination of the absolute configuration of 1, the 
solution TDDFT-ECD approach was utilized.10,11 The initial 
Merck Molecular Force Field (MMFF) conformational search of 
the arbitrarily chosen (5S,6S,8S,9S,4'S) enantiomer resulted in 9 
conformers in a 21 kJ/mol energy window indicating low 
flexibility of the molecule. Reoptimization of these conformers at 
the B3LYP/6-31G(d) in vacuo and the B97D/TZVP12,13 
PCM/MeCN levels each yielded 6 low-energy conformers over 
1% Boltzmann population differing only in the orientations of the 
3-OH and the 8-OH groups (Figure 4). The interatomic distances 
and dihedral angles of the computed conformers were in 
agreement with the observed ROESY correlations and 3JH,H data 
confirming the relative configuration. The computed ECD spectra 
of the individual conformers of (5S,6S,8S,9S,4'S)-1 were rather 
similar and the Boltzmann-weighted average ECD spectrum gave 
a nice mirror-image overall agreement with the experimental ECD 
spectrum (Figure 5) allowing unambiguous elucidation of the 
absolute configuration of 1 as (5R,6R,8R,9R,4'R). 
 
 
Figure 4. Six overlapped low-energy (> 1%) solution 
conformers of (5S,6S,8S,9S,4'S)-1 with Boltzmann populations of 
20.3%, 20.3%, 19.3%, 19.2%, 10.1% and 9.7% indicating that they 
differ only in the orientation of two OH protons. Level of 
optimization: B97D/TZVP PCM/MeCN. 
 
Figure 5. Experimental ECD spectrum of 1 in MeCN (black 
curve) compared with the Boltzmann-weighted 
BH&HLYP/TZVP PCM/MeCN ECD spectrum of 
(5S,6S,8S,9S,4'S)-1 (red curve) computed for the six low-energy 
(> 1%) B97D/TZVP PCM/MeCN conformers. Bars represent the 
rotational strengths of the lowest-energy conformer. 
 
Since for similar fused ten-membered ring systems there are 
examples for both cis and trans annulations,14,15 a TDDFT-ECD 
study was also performed on the C-8 epimer having cis ring 
annulations of the ten-membered and (5S,6S,8S,9S,4'S) absolute 
configuration to confirm our assignment of relative configuration 
and exclude the cis annulated stereoisomer. MMFF 
conformational search performed on the arbitrarily chosen 
(5S,6S,8R,9S,4'S) enantiomer resulted in 38 conformers in a 21 
kJ/mol energy window indicating higher flexibility of the C-8 
epimer. Reoptimization of these conformers at the above 
mentioned DFT levels yielded 14 (supporting information Figure 
S14) and 1 low-energy conformers over 2% Boltzmann population 
(Figure 6), respectively. The geometry of the computed 
conformers contradicted the observed ROESY correlations. 
ECD spectra computed for both sets of conformers gave 
mirror-image agreement for the two high-wavelength transitions 
but in the range of 205-260 nm region the computed and 
experimental transitions did not match (Figure 7). Thus, TDDFT-
ECD calculations of the (5S,6S,8R,9S,4'S) stereoisomer could also 
exclude this possibility, and verified the above (5R,6R,8R,9R,4'R) 
absolute configuration for 1. 
 
 
Figure 6. B97D/TZVP PCM/MeCN optimized single low-
energy (> 2%) conformer of (5S,6S,8R,9S,4'S)-1 with a 
Boltzmann population of 91.6%. 
 
 
Figure 7. Experimental ECD spectrum of 1 in MeCN (black 
curve) compared with the Boltzmann-weighted PCM/MeCN ECD 
spectra of (5S,6S,8R,9S,4'S)-1 computed at various levels (red, 
blue and purple lines) for the single low-energy (> 1%) 
B97D/TZVP PCM/MeCN conformer. 
 
A plausible biosynthetic pathway of 1 includes the 
condensation of an acetyl-CoA starter unit and four malonyl-CoA 
extender units to generate a pentaketide. The latter would then 
undergo cyclization and aromatization reactions to form 1,3,6,8-
tetrahydroxynaphthalene (4THN), which is in equilibrium with 
6,8-dihydroxy-1,3(2H,4H)-naphthalenedione16,17, both 
compounds being closely related to 3,4-dihydro-3,4,6,8-
tetrahydroxy-l(2H)-naphthalenone and (R)-scytalone, which have 
been previously isolated from the same Annulohypoxylon sp. 
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strain.9 Alternatively, the initial pentaketide could undergo 
regiospecific reduction, dehydration, and lactonization to yield the 
10-membered macrolide diplodialide A, a known metabolite from 
the fungus Diplodia pinea.18,19 Finally, tandem Michael-aldol 
addition of these subunits and subsequent hydroxylation at 
position 5 would result in the formation of 1 (Figure 8). 
 
 
Figure 8. Proposed biosynthesis of 1. 
 
Hypoxylide (1) was screened for cytotoxicity against mouse 
lymphoma (L5178Y), human leukemia (Jurkat J16), and human 
lymphoma (Ramos) cell lines using the MTT assay, as well as for 
its antibacterial activity against Staphylococcus aureus ATCC 
25923, Acinetobacter baumannii ATCC BAA747, and 
Mycobacterium tuberculosis. However, compound 1 did not show 
any detectable activity when assayed at an initial dose of 10 µM. 
In conclusion, a new 10-membered macrolactone, 
hypoxylide (1), was isolated and characterized from a 
Mangrove-derived endophytic fungus belonging to 
Annulohypoxylon genus. The structure and absolute 
configuration of 1 were unambiguously established by 
comprehensive 1D and 2D NMR, along with HRESIMS and 
ECD spectroscopic analysis. Compound 1 features a unique 
polyketide scaffold bearing a trihydroxynaphthalene-dione 
moiety fused to a decalactone ring. The latter moiety 
resembles that found in benzenediol lactones (BDLs) (e.g., 
curvularin and sonnerlactones);20,21 however, to the best of 
our knowledge, the present study represents the first example 
of a 1,3-fused ten-membered ring system forming an unusual 
C-6 – C-8 coupling pattern in the structure of 1. Notably, 
molecular studies have shown that BDLs are biosynthesized 
by two sequentially acting iterative polyketide synthases,20,22 
thus producing chimeric scaffolds, which is in accordance 
with the proposed biosynthetic pathway of 1 involving the 
linkage of two pentaketides, 6,8-dihydroxy-1,3(2H,4H)-
naphthalenedione and diplodialide A. Overall, the novel 
structure of 1 not only expands the structural diversity of 
polyketide lactone scaffolds in nature, but also provides 
further insights into their biogenesis, thus offering an 
attractive target for synthetic and biosynthetic research 
communities alike. 
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